By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mitochondrial mutations could hold new opportunities for researchers seeking to develop cancer diagnostics, according to the National Cancer Institute, which has issued a new grant program to fund scientists who will study this possibility.

NCI plans to fund research that will validate new mitochondrial-related cancer biomarkers for early detection, diagnosis, prognosis, risk assessment, and response to treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.